-
EP2170353
European procedure
Extract from the Register of European Patents
EP About this file: EP2170353
| EP2170353 - PHOSPHATE-MODIFIED OLIGONUCLEOTIDE ANALOGS WITH IMMUNOSTIMULATORY ACTIVITY [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 08.04.2016 Database last updated on 31.08.2024 | Most recent event Tooltip | 08.04.2016 | No opposition filed within time limit | published on 11.05.2016 [2016/19] | Applicant(s) | For all designated states AdiuTide Pharmaceuticals GmbH Alt Fechenheim 34 60386 Frankfurt am Main / DE | [2011/36] |
| Former [2010/32] | For all designated states Uhlmann, Eugen Zum Talblick 31 61479 Glashütten / DE | ||
| Former [2010/14] | For all designated states Coley Pharmaceutical GmbH Merowingerplatz 1a 40225 Düsseldorf / DE | Inventor(s) | 01 /
JURK, Marion Klosterstr. 4 41540 Dormagen / DE | 02 /
UHLMANN, Eugen Zum Talblick 31 61479 Glashuetten / DE | [2010/14] | Representative(s) | Kalhammer, Georg, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE | [2015/23] |
| Former [2010/25] | Kalhammer, Georg, et al Lederer & Keller Patentanwälte Prinzregentenstrasse 16 80538 München / DE | ||
| Former [2010/14] | Porter, Jonathan Philip Pfizer Limited European Patent Department IPC 748 Ramsgate Road Sandwich, Kent CT13 9NJ / GB | Application number, filing date | 08750947.7 | 15.05.2008 | [2010/14] | WO2008IB01206 | Priority number, date | US20070930764P | 18.05.2007 Original published format: US 930764 P | [2010/14] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2008142513 | Date: | 27.11.2008 | Language: | EN | [2008/48] | Type: | A2 Application without search report | No.: | EP2170353 | Date: | 07.04.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.11.2008 takes the place of the publication of the European patent application. | [2010/14] | Type: | B1 Patent specification | No.: | EP2170353 | Date: | 03.06.2015 | Language: | EN | [2015/23] | Search report(s) | International search report - published on: | EP | 27.08.2009 | Classification | IPC: | A61P37/08, A61K47/48, A61K31/7125, A61K45/06, A61P35/00, A61P31/00, A61P11/06, A61P37/00 | [2014/27] | CPC: |
C12N15/117 (EP,US);
A61K31/7125 (EP,US);
A61K45/06 (EP,US);
A61P11/00 (EP);
A61P11/06 (EP);
A61P31/00 (EP);
A61P35/00 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
A61P37/04 (EP);
A61P37/08 (EP);
C12N2310/17 (EP,US);
C12N2310/311 (EP,US);
C12N2310/3125 (EP,US);
C12N2310/315 (EP,US);
Y02A50/30 (EP,US)
(-)
| C-Set: |
A61K31/7125, A61K2300/00 (EP,US)
|
| Former IPC [2010/14] | A61K31/7125, A61K45/06, A61P35/00, A61P31/00, A61P11/06, A61P37/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2015/23] |
| Former [2010/14] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Title | German: | PHOSPHAT-MODIFIZIERTE OLIGONUCLEOTID-ANALOGA MIT IMMUNOSTIMULATORISCHER WIRKUNG | [2010/14] | English: | PHOSPHATE-MODIFIED OLIGONUCLEOTIDE ANALOGS WITH IMMUNOSTIMULATORY ACTIVITY | [2010/14] | French: | ANALOGUES D'OLIGONUCLÉOTIDES MODIFIÉS PAR PHOSPHATE, PRÉSENTANT UNE ACTIVITÉ IMMUNOSTIMULANTE AMÉLIORÉE | [2010/14] | Entry into regional phase | 18.12.2009 | National basic fee paid | 01.03.2010 | Designation fee(s) paid | 01.03.2010 | Examination fee paid | Examination procedure | 09.12.2009 | Amendment by applicant (claims and/or description) | 01.03.2010 | Examination requested [2010/14] | 07.06.2010 | Despatch of a communication from the examining division (Time limit: M06) | 15.11.2010 | Reply to a communication from the examining division | 01.07.2013 | Despatch of a communication from the examining division (Time limit: M04) | 11.11.2013 | Reply to a communication from the examining division | 20.03.2014 | Despatch of a communication from the examining division (Time limit: M02) | 16.05.2014 | Reply to a communication from the examining division | 13.06.2014 | Communication of intention to grant the patent | 01.12.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time | 02.02.2015 | Fee for grant paid | 02.02.2015 | Fee for publishing/printing paid | 02.02.2015 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 07.06.2010 | Opposition(s) | 04.03.2016 | No opposition filed within time limit [2016/19] | Request for further processing for: | The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent | 02.02.2015 | Request for further processing filed | 02.02.2015 | Full payment received (date of receipt of payment) Request granted | 13.02.2015 | Decision despatched | Fees paid | Renewal fee | 27.05.2010 | Renewal fee patent year 03 | 26.05.2011 | Renewal fee patent year 04 | 29.03.2012 | Renewal fee patent year 05 | 28.05.2013 | Renewal fee patent year 06 | 27.05.2014 | Renewal fee patent year 07 | 21.04.2015 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]US6693187 (DELLINGER DOUGLAS J [US]) [X] 1 * column 9, lines 15-40; compound FORMULA X * * claim 3 *; | [Y]WO2006116458 (COLEY PHARM GMBH [DE], et al) [Y] 1-15 * page 4, lines 10-25 * * claim 1 *; | [A]WO2004005476 (COLEY PHARM GROUP INC [US]) [A] 1-15 * page 38, lines 18-31 *; | [A]US2004198688 (KRIEG ARTHUR M [US], et al) [A] 1-15 * paragraphs [0063] , [0064] *; | [A]US6207646 (KRIEG ARTHUR M [US], et al) [A] 1-15 * example 10 * | [X] - DELLINGER DOUGLAS J ET AL, "Oligodeoxyribonucleotide analogs functionalized with phosphonoacetate and thiophosphonoacetate diesters.", CURRENT PROTOCOLS IN NUCLEIC ACID CHEMISTRY / EDITED BY SERGE L. BEAUCAGE ... [ET AL.] OCT 2004, (200410), vol. Chapter 4, ISSN 1934-9289, page Unit 4.24, XP008107901 [X] 1-3 * table 4.24.5 * | [XY] - SHEEHAN DAVID ET AL, "Biochemical properties of phosphonoacetate and thiophosphonoacetate oligodeoxyribonucleotides.", NUCLEIC ACIDS RESEARCH 15 JUL 2003, (20030715), vol. 31, no. 14, ISSN 1362-4962, pages 4109 - 4118, XP002534849 [X] 1-3 * abstract * * page 4112; table 1 * * page 4115, column 1, paragraph LAST - column 2, paragraph 1 * * page 4117, column 2, paragraph LAST * [Y] 1-15 DOI: http://dx.doi.org/10.1093/NAR/GKG439 | [A] - RUDOLPH M JONATHAN ET AL, "PHOSPHONOACETATE DERIVATIVES OF OLIGODEOXYRIBONUCLEOTIDES", NUCLEOSIDES & NUCLEOTIDES, MARCEL DEKKER, INC, US, (19960101), vol. 15, no. 11-12, ISSN 0732-8311, pages 1725 - 1739, XP009074695 [A] 1-15 | [A] - MUTWIRI G K ET AL, "Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, (20040531), vol. 97, no. 1, ISSN 0168-3659, pages 1 - 17, XP004508971 [A] 1-15 DOI: http://dx.doi.org/10.1016/j.jconrel.2004.02.022 | Examination | - UHLMANN EUGEN, Immune stimulatory oligonucleotides, THERAPEUTIC OLIGONUCLEOTIDES ROYAL SOC CHEMISTRY, THOMAS GRAHAM HOUSE, SCIENCE PARK, CAMBRIDGE CB4 4WF, CAMBS, UK SERIES : RSC BIOMOLECULAR SCIENCES (ISSN 1757-7152(PRINT)), PAGE(S) 142-162, (2008), ISSN null | - RUTZ MARK ET AL, "Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner", EUROPEAN JOURNAL OF IMMUNOLOGY, (200409), vol. 34, no. 9, ISSN 0014-2980, pages 2541 - 2550 | - AGRAWAL SUDHIR ET AL, "Medicinal chemistry and therapeutic potential of CpG DNA", TRENDS IN MOLECULAR MEDICINE, (200203), vol. 8, no. 3, ISSN 1471-4914, pages 114 - 121 |